Found: 6
Select item for more details and to access through your institution.
Development of a Physiologically Based Pharmacokinetic Model for Tegoprazan: Application for the Prediction of Drug–Drug Interactions with CYP3A4 Perpetrators.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 182, doi. 10.3390/pharmaceutics15010182
- By:
- Publication type:
- Article
Clinical Evaluation of Acetaminophen–Galgeuntang Interaction Based on Population Approaches.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 12, p. 1182, doi. 10.3390/pharmaceutics12121182
- By:
- Publication type:
- Article
Effects of Carbamazepine and Phenytoin on Pharmacokinetics and Pharmacodynamics of Rivaroxaban.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 11, p. 1040, doi. 10.3390/pharmaceutics12111040
- By:
- Publication type:
- Article
Application of the Population Pharmacokinetics Model-Based Approach to the Prediction of Drug–Drug Interaction between Rivaroxaban and Carbamazepine in Humans.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 5, p. 684, doi. 10.3390/ph16050684
- By:
- Publication type:
- Article
Application of an Inter-Species Extrapolation Method for the Prediction of Drug Interactions between Propolis and Duloxetine in Humans.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 5, p. 1862, doi. 10.3390/ijms21051862
- By:
- Publication type:
- Article
Application of physiologically‐based pharmacokinetic model approach to predict pharmacokinetics and drug–drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 11, p. 1430, doi. 10.1002/psp4.12844
- By:
- Publication type:
- Article